| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York 10032 [H. A. P., M. J. F., A. C., V. V. V. S. M.]; Departments of Genetics, Pathology, Gynecology, and Epidemiology, Instituto Nacional de Cancerología, Santa Fe de Bogotá, Colombia [H. A. P., N. B., G. M., H. P.]; Southwestern Medical Center, Dallas, Texas 75390 [E. D. E., G. A. E.]; and Department of Zoology, North-Eastern Hill University, Shillong, 793022 India [A. C.]
Previous functional and deletion mapping studies on cervical cancer (CC) have implicated one or more tumor suppressor genes (TSGs) on chromosome 11 at q13 and q2224 regions. Of these, the 11q2224 region exhibits frequent allelic deletions in a variety of solid tumor types, suggesting the presence of critical genes for tumor suppression in this region. However, the precise region of deletion on 11q is not clearly defined in CC. In an attempt to accurately map the deleted region, we performed an extensive loss of heterozygosity (LOH) mapping in 58 tumors using 25 polymorphic loci on both the short and long arms. The pattern of LOH identified three sites of deletions, two on 11p (p15.11p15.3 and p1213), and one on 11q (q23.1q23.2). The 11q23.1q23.2 exhibited highest frequency (60.6%) of deletions, suggesting that this could be the site of a candidate TSG in CC. The minimal deletion at 11q23.123.2 was restricted to a 6-cM region between 123.5 and 129.5 cM genetic distance on chromosome 11, identifying the site of a potential TSG important in the pathogenesis of CC. At least five known genes and 28 UniGene clusters were mapped to the present commonly deleted region. In addition, we have excluded a previously known TSG PPP2R1B at 11q23 as a deletion target in CC. The definition of the minimal deletion and the availability of expressed sequence resources should facilitate the identification of the candidate TSG.
This article has been cited by other articles:
![]() |
R. E. Dickinson, M. Myers, and W. C. Duncan Novel Regulated Expression of the SLIT/ROBO Pathway in the Ovary: Possible Role during Luteolysis in Women Endocrinology, October 1, 2008; 149(10): 5024 - 5034. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Diederichs and D. A. Haber Sequence Variations of MicroRNAs in Human Cancer: Alterations in Predicted Secondary Structure Do Not Affect Processing. Cancer Res., June 15, 2006; 66(12): 6097 - 6104. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Arias-Pulido, C. L. Peyton, N. E. Joste, H. Vargas, and C. M. Wheeler Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol., May 1, 2006; 44(5): 1755 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Narayan, H. Arias-Pulido, S. V. Nandula, K. Basso, D. D. Sugirtharaj, H. Vargas, M. Mansukhani, J. Villella, L. Meyer, A. Schneider, et al. Promoter Hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA Pathway in Cervical Cancer Cancer Res., May 1, 2004; 64(9): 2994 - 2997. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. M. Steenbergen, D. Kramer, B. J. M. Braakhuis, P. L. Stern, R. H. M. Verheijen, C. J. L. M. Meijer, and P. J. F. Snijders TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical Neoplasia J Natl Cancer Inst, February 18, 2004; 96(4): 294 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Martin, R. Cesari, F. Pentimalli, K. Yoder, R. Fishel, A. L. Himelstein, S. E. Martin, A. K. Godwin, M. Negrini, and C. M. Croce The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene PNAS, September 30, 2003; 100(20): 11517 - 11522. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Mondal, A Tripathi, N Bhattacharya, N Sikdar, A Roy, A Sengupta, B Roy, C K Panda, and S Roychoudhury Allelic imbalance at chromosome 11 in head and neck squamous cell carcinoma in an Indian patient population J. Clin. Pathol., July 1, 2003; 56(7): 512 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chatterjee, H. A. Pulido, S. Koul, N. Beleño, A. Perilla, H. Posso, M. Manusukhani, and V. V. V. S. Murty Mapping the Sites of Putative Tumor Suppressor Genes at 6p25 and 6p21.3 in Cervical Carcinoma: Occurrence of Allelic Deletions in Precancerous Lesions Cancer Res., March 1, 2001; 61(5): 2119 - 2123. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |